CD47-Targeted Near-Infrared Photoimmunotherapy for Human Bladder Cancer.
Bernhard KissNynke S van den BergRobert ErtseyKelly McKennaKathleen E MachChiyuan Amy ZhangJens-Peter VolkmerIrving L WeissmanEben L RosenthalJoseph C LiaoPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)
CD47-targeted NIR-PIT increased direct cancer cell death and phagocytosis resulting in inhibited tumor growth and improved survival in a murine xenograft model of human bladder cancer.